{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:58:02Z","timestamp":1789102682103,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PNRR-POC-2023-12377196"],"award-info":[{"award-number":["PNRR-POC-2023-12377196"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["C63C24000310006"],"award-info":[{"award-number":["C63C24000310006"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.nbd.2026.107415","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T22:24:35Z","timestamp":1777242275000},"page":"107415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Plasma NfL, GFAP and pTau181 define distinct biological axes in amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"224","author":[{"given":"Gianmaria","family":"Senerchia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Virginia","family":"Iuzzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Spisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Panico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Aruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Fiorenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Sirica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Dubbioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107415_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-57144-7","article-title":"Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis","volume":"16","author":"Abu-Rumeileh","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2026.107415_bb0010","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1093\/brain\/awac394","article-title":"Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal","volume":"146","author":"Benatar","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107415_bb0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","article-title":"El Escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"124","author":"Brooks","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2026.107415_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2026.107415_bb0025","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","article-title":"Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study","volume":"82","author":"Chio","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107415_bb0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00415-022-11404-4","article-title":"Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis","volume":"270","author":"Colombo","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2026.107415_bb0035","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ana.26462","article-title":"Elevated plasma phosphorylated tau 181 in amyotrophic lateral sclerosis","volume":"92","author":"Cousins","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2026.107415_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-024-03597-2","article-title":"Voice signals database of ALS patients with different dysarthria severity and healthy controls","volume":"11","author":"Dubbioso","year":"2024","journal-title":"Sci. Data"},{"key":"10.1016\/j.nbd.2026.107415_bb0045","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/ene.15321","article-title":"Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis","volume":"29","author":"Falzone","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2026.107415_bb0050","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2026.107415_bb0055","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107415_bb0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/nan.12511","article-title":"Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with amyotrophic lateral sclerosis","volume":"45","author":"Gille","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2026.107415_bb0065","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.clinph.2012.01.010","article-title":"A practical guide to diagnostic transcranial magnetic stimulation: report of an IFCN committee","volume":"123","author":"Groppa","year":"2012","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.nbd.2026.107415_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-023-00685-6","article-title":"Fluid biomarkers for amyotrophic lateral sclerosis: a review","author":"Irwin","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2026.107415_bb0075","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/acn3.52095","article-title":"Threshold tracking transcranial magnetic stimulation and neurofilament light chain as diagnostic aids in ALS","volume":"11","author":"Jacobsen","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2026.107415_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70208","article-title":"A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer\u2019s disease","volume":"21","author":"Janelidze","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2026.107415_bb0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","article-title":"Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS","volume":"66","author":"Kimura","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107415_bb0090","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213400","article-title":"Comparative performances of 4 serum NfL assays, pTau181, and GFAP in patients with amyotrophic lateral sclerosis","volume":"104","author":"Mondesert","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107415_bb0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/jnnp.63.1.89","article-title":"A self report measure of affective lability","volume":"63","author":"Moore","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107415_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70382","article-title":"Diagnostic and prognostic value of blood and cerebrospinal fluid biomarkers in amyotrophic lateral sclerosis: a systematic review and Meta-analysis","volume":"32","author":"Obara","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2026.107415_bb0105","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","article-title":"Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease","volume":"88","author":"Poesen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107415_bb0110","series-title":"Electromyography and neuromuscular disorders","author":"Preston","year":"2013"},{"key":"10.1016\/j.nbd.2026.107415_bb0115","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/mus.26764","article-title":"Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis","volume":"61","author":"Quinn","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2026.107415_bb0120","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.27305","article-title":"Cortical excitability as a prognostic and phenotypic stratification biomarker in amyotrophic lateral sclerosis","volume":"98","author":"Ranieri","year":"2025","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2026.107415_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70171","article-title":"Identifying mild behavioral and neurocognitive impairment in amyotrophic lateral sclerosis (MBNI-ALS) provides key prognostic insights","volume":"32","author":"Spisto","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2026.107415_bb0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","article-title":"Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria","volume":"18","author":"Strong","year":"2017","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"10.1016\/j.nbd.2026.107415_bb0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11682-022-00744-4","article-title":"Resting state fMRI analysis of pseudobulbar affect in amyotrophic lateral sclerosis (ALS): motor dysfunction of emotional expression","volume":"17","author":"Trojsi","year":"2023","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.nbd.2026.107415_bb0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/jnnp-2019-322541","article-title":"Primary lateral sclerosis: consensus diagnostic criteria","volume":"91","author":"Turner","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107415_bb0145","series-title":"A companion to peripheral nervous system examination","author":"Uncini","year":"2025"},{"key":"10.1016\/j.nbd.2026.107415_bb0150","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jnnp-2022-330709","article-title":"Elevated plasma p-tau181 levels unrelated to alzheimers disease pathology in amyotrophic lateral sclerosis","volume":"94","author":"Vacchiano","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107415_bb0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","article-title":"Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis","volume":"90","author":"Verde","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107415_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.679199","article-title":"Neurofilament light chain as biomarker for amyotrophic lateral sclerosis and frontotemporal dementia","volume":"15","author":"Verde","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2026.107415_bb0165","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1007\/s10072-023-06916-4","article-title":"Phosphorylated tau in plasma could be a biomarker of lower motor neuron impairment in amyotrophic lateral sclerosis","volume":"44","author":"Verde","year":"2023","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nbd.2026.107415_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1132808","article-title":"Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis","volume":"15","author":"Verde","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2026.107415_bb0175","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/acn3.51708","article-title":"Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis","volume":"10","author":"Verde","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2026.107415_bb0180","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ana.27054","article-title":"Population-based evidence for the use of serum neurofilaments as individual diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis","volume":"96","author":"Witzel","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2026.107415_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16154","article-title":"Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis\u2014insights from a completed randomized controlled trial with rasagiline","volume":"31","author":"Witzel","year":"2024","journal-title":"Eur. J. Neurol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126001609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126001609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:26:06Z","timestamp":1785151566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126001609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"alternative-id":["S0969996126001609"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107415","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma NfL, GFAP and pTau181 define distinct biological axes in amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107415"}}